Cargando…

A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients

PURPOSE: Autophagy plays a crucial role in the initiation and progression of gastric cancer (GC). However, the role of autophagy-related lncRNAs in GC remains unknown. This study aimed to investigate the prognostic value of the autophagy-related lncRNA signature and its role in the tumor immune micr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Di, Wang, Mengmeng, Xu, Yushuang, Jiang, Xin, Xiong, Lina, Zhang, Li, Yu, Honglu, Xiong, Zhifan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541751/
https://www.ncbi.nlm.nih.gov/pubmed/34703297
http://dx.doi.org/10.2147/IJGM.S331959
_version_ 1784589305037979648
author Chen, Di
Wang, Mengmeng
Xu, Yushuang
Jiang, Xin
Xiong, Lina
Zhang, Li
Yu, Honglu
Xiong, Zhifan
author_facet Chen, Di
Wang, Mengmeng
Xu, Yushuang
Jiang, Xin
Xiong, Lina
Zhang, Li
Yu, Honglu
Xiong, Zhifan
author_sort Chen, Di
collection PubMed
description PURPOSE: Autophagy plays a crucial role in the initiation and progression of gastric cancer (GC). However, the role of autophagy-related lncRNAs in GC remains unknown. This study aimed to investigate the prognostic value of the autophagy-related lncRNA signature and its role in the tumor immune microenvironment (TIME) of GC. METHODS: RNA-sequencing (RNA-seq) and clinical data of GC patients were extracted from The Cancer Genome Atlas (TCGA) database. Univariate and multivariate Cox regression analyses were performed to identify the autophagy-related lncRNA prognostic signature which was validated in the test set and entire set. The survival and predictive performance were analyzed based on the Kaplan–Meier and ROC curves. Furthermore, the CIBERSORT algorithm was applied to explore the relationship between this signature and the immune cell infiltration. To elucidate the potential functions of autophagy-related lncRNAs in GC, we constructed the lncRNA-mRNA co-expression network and performed enrichment analysis. Principal component analysis (PCA) and Gene Set Enrichment Analysis (GSEA) were further performed to compare the different statuses between the high-risk and low-risk groups. RESULTS: We identified 5 autophagy-related lncRNAs (AL355574.1, AC010768.2, AP000695.2, AC087286.2, and HAGLR) to construct a prognostic signature. This signature could be an independent prognostic indicator for GC patients and had a higher prediction efficiency than other clinicopathological parameters. Furthermore, patients in the high-risk score group had a stronger immunosuppressive microenvironment than the low-risk group. The enrichment analysis for mRNAs co-expressed with these lncRNAs indicated that autophagy-related signaling pathways were remarkably enriched. PCA and GSEA further revealed different autophagy and immune statuses in the high- and low-risk groups. CONCLUSION: The 5 autophagy-related lncRNA signature has significant clinical implications in prognosis prediction of GC. Meanwhile, our study elucidates the critical role of the autophagy-related lncRNA signature in the TIME of GC.
format Online
Article
Text
id pubmed-8541751
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85417512021-10-25 A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients Chen, Di Wang, Mengmeng Xu, Yushuang Jiang, Xin Xiong, Lina Zhang, Li Yu, Honglu Xiong, Zhifan Int J Gen Med Original Research PURPOSE: Autophagy plays a crucial role in the initiation and progression of gastric cancer (GC). However, the role of autophagy-related lncRNAs in GC remains unknown. This study aimed to investigate the prognostic value of the autophagy-related lncRNA signature and its role in the tumor immune microenvironment (TIME) of GC. METHODS: RNA-sequencing (RNA-seq) and clinical data of GC patients were extracted from The Cancer Genome Atlas (TCGA) database. Univariate and multivariate Cox regression analyses were performed to identify the autophagy-related lncRNA prognostic signature which was validated in the test set and entire set. The survival and predictive performance were analyzed based on the Kaplan–Meier and ROC curves. Furthermore, the CIBERSORT algorithm was applied to explore the relationship between this signature and the immune cell infiltration. To elucidate the potential functions of autophagy-related lncRNAs in GC, we constructed the lncRNA-mRNA co-expression network and performed enrichment analysis. Principal component analysis (PCA) and Gene Set Enrichment Analysis (GSEA) were further performed to compare the different statuses between the high-risk and low-risk groups. RESULTS: We identified 5 autophagy-related lncRNAs (AL355574.1, AC010768.2, AP000695.2, AC087286.2, and HAGLR) to construct a prognostic signature. This signature could be an independent prognostic indicator for GC patients and had a higher prediction efficiency than other clinicopathological parameters. Furthermore, patients in the high-risk score group had a stronger immunosuppressive microenvironment than the low-risk group. The enrichment analysis for mRNAs co-expressed with these lncRNAs indicated that autophagy-related signaling pathways were remarkably enriched. PCA and GSEA further revealed different autophagy and immune statuses in the high- and low-risk groups. CONCLUSION: The 5 autophagy-related lncRNA signature has significant clinical implications in prognosis prediction of GC. Meanwhile, our study elucidates the critical role of the autophagy-related lncRNA signature in the TIME of GC. Dove 2021-10-19 /pmc/articles/PMC8541751/ /pubmed/34703297 http://dx.doi.org/10.2147/IJGM.S331959 Text en © 2021 Chen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Chen, Di
Wang, Mengmeng
Xu, Yushuang
Jiang, Xin
Xiong, Lina
Zhang, Li
Yu, Honglu
Xiong, Zhifan
A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients
title A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients
title_full A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients
title_fullStr A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients
title_full_unstemmed A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients
title_short A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients
title_sort novel autophagy-related lncrna prognostic signature associated with immune microenvironment and survival outcomes of gastric cancer patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541751/
https://www.ncbi.nlm.nih.gov/pubmed/34703297
http://dx.doi.org/10.2147/IJGM.S331959
work_keys_str_mv AT chendi anovelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT wangmengmeng anovelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT xuyushuang anovelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT jiangxin anovelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT xionglina anovelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT zhangli anovelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT yuhonglu anovelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT xiongzhifan anovelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT chendi novelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT wangmengmeng novelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT xuyushuang novelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT jiangxin novelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT xionglina novelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT zhangli novelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT yuhonglu novelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients
AT xiongzhifan novelautophagyrelatedlncrnaprognosticsignatureassociatedwithimmunemicroenvironmentandsurvivaloutcomesofgastriccancerpatients